Financials
- Market Capitalization 10.9 B
- Employee 915
- Founded 2011
- CEO Paul A. Friedman
- Website www.madrigalpharma.com
- Headquarter Delaware, United States
- FIGI BBG000QS6NV8
- Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-45.32
市销率
13.63
Related tickers
| # | 姓名 | 价格 | 24小时 % | 7天 % | 一个月 % | 一年 % | 市值 | 最近7天 | |
|---|---|---|---|---|---|---|---|---|---|
| 829 | TECH Bio-Techne Corp - Common Stock | 72.46 USD | +0.01% | +0.07% | +0.35% | +22.09% | 11.36 B USD | ||
| 834 | IBRX ImmunityBio, Inc. - Common Stock | 10.51 USD | +6.05% | -2.32% | +33.21% | +341.60% | 11.14 B USD | ||
| 857 | PCVX Vaxcyte, Inc. - Common Stock | 71.38 USD | +9.78% | -18.15% | +18.89% | +68.75% | 10.62 B USD | ||
| 859 | BMRN BioMarin Pharmaceutical Inc. - Common Stock | 54.80 USD | -0.16% | -4.04% | -17.59% | +4.68% | 10.61 B USD |